Fimmcyte
Basel, CH · 1 known investors
FimmCyte is a Swiss biotech developing targeted immunotherapies for endometriosis and other chronic fibro-inflammatory diseases, using a platform that targets a protein overexpressed in fibrotic tissue to eliminate diseased cells while preserving healthy ones. Its lead candidate, FMC, is an antifibrotic therapy addressing unmet needs in women's health.</parameter> <parameter name="founders">[]
BiotechDigital HealthFemTech
Investors · 1
Frequently asked questions
- What does Fimmcyte do?
- FimmCyte is a Swiss biotech developing targeted immunotherapies for endometriosis and other chronic fibro-inflammatory diseases, using a platform that targets a protein overexpressed in fibrotic tissue to eliminate diseased cells while preserving healthy ones. Its lead candidate, FMC, is an antifibrotic therapy addressing unmet needs in women's health.</parameter> <parameter name="founders">[]
- Who are Fimmcyte's investors?
- Fimmcyte's investors include Kickfund.
- Where is Fimmcyte headquartered?
- Fimmcyte is headquartered in Basel, CH.